[go: up one dir, main page]

GB202305813D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB202305813D0
GB202305813D0 GBGB2305813.4A GB202305813A GB202305813D0 GB 202305813 D0 GB202305813 D0 GB 202305813D0 GB 202305813 A GB202305813 A GB 202305813A GB 202305813 D0 GB202305813 D0 GB 202305813D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2305813.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Artios Pharma Ltd
Original Assignee
Artios Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Artios Pharma Ltd filed Critical Artios Pharma Ltd
Priority to GBGB2305813.4A priority Critical patent/GB202305813D0/en
Publication of GB202305813D0 publication Critical patent/GB202305813D0/en
Priority to PCT/GB2024/051015 priority patent/WO2024218499A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB2305813.4A 2023-04-20 2023-04-20 Novel compounds Ceased GB202305813D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2305813.4A GB202305813D0 (en) 2023-04-20 2023-04-20 Novel compounds
PCT/GB2024/051015 WO2024218499A1 (en) 2023-04-20 2024-04-19 Heterocyclic inhibitors of dna polymerase theta for the treatment of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2305813.4A GB202305813D0 (en) 2023-04-20 2023-04-20 Novel compounds

Publications (1)

Publication Number Publication Date
GB202305813D0 true GB202305813D0 (en) 2023-06-07

Family

ID=86605384

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2305813.4A Ceased GB202305813D0 (en) 2023-04-20 2023-04-20 Novel compounds

Country Status (2)

Country Link
GB (1) GB202305813D0 (en)
WO (1) WO2024218499A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10760081B2 (en) 2015-10-07 2020-09-01 New York University Compositions and methods for enhancing CRISPR activity by POLQ inhibition
WO2021028643A1 (en) * 2019-08-09 2021-02-18 Artios Pharma Limited Heterocyclic compounds for use in the treatment of cancer
GB201918587D0 (en) * 2019-12-17 2020-01-29 Artios Pharma Ltd Novel compounds
WO2022026565A1 (en) * 2020-07-29 2022-02-03 Ideaya Biosciences, Inc. Cyclized acetamido derivatives as dna polymerase theta inhibitors
CN115960079B (en) * 2023-03-16 2023-05-09 英矽智能科技(上海)有限公司 Azetidine derivatives, their preparation and their use in medicine

Also Published As

Publication number Publication date
WO2024218499A1 (en) 2024-10-24

Similar Documents

Publication Publication Date Title
GB202202921D0 (en) Novel compounds
GB202302686D0 (en) Novel compounds
GB202319938D0 (en) Novel compounds
GB202319820D0 (en) Novel compounds
GB202318867D0 (en) Novel compounds
GB202318866D0 (en) Novel compounds
GB202318175D0 (en) Novel compounds
GB202317236D0 (en) Novel compounds
GB202316971D0 (en) Novel compounds
GB202316974D0 (en) Novel compounds
GB202316973D0 (en) Novel compounds
GB202316972D0 (en) Novel compounds
GB202316975D0 (en) Novel compounds
GB202315015D0 (en) Novel compounds
GB202310221D0 (en) Novel compounds
GB202310218D0 (en) Novel compounds
GB202308147D0 (en) Novel compounds
GB202308148D0 (en) Novel compounds
GB202307972D0 (en) Novel compounds
GB202307797D0 (en) Novel compounds
GB202307427D0 (en) Novel compounds
GB202307426D0 (en) Novel compounds
GB202305813D0 (en) Novel compounds
GB202305812D0 (en) Novel compounds
GB202304448D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)